BXRX

Baudax Bio, Inc. Common Stock
BXRX

Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

12 hedge funds and large institutions have $152K invested in Baudax Bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$52.7K
2
+$32K
3
+$11.3K
4
TRCT
Tower Research Capital (TRC)
New York
+$10.5K
5
Wells Fargo
Wells Fargo
California
+$48

Top Sellers

1
-$55.8K
2
-$3K
3
-$1.79K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$52.7K
2
$32K
3
$29.1K
4
$13.6K
5
$12.4K
6
$11.3K
7
$932
8
$51
9
$24
10
$5
11
$1
12
$1
13
–
14
–
15
–